glp-1 oral health news FDA approves Foundayo, an alternative to Wegovy and Ozempic Ozempic and Oral Health: What

For some patients, the goal is to have more good days than bad

The process for a compounded drug does not include this testing

This is a breakthrough, since diabetes is the leading cause of kidney disease worldwide

Noom first launched its GLP-1 Companion in November 2023 and has continued to invest heavily in the program since launch, adding features like Muscle Defense, AI food logging, medication tracking and side effect support, AI-powered body composition scans, glucose curve forecasting, stress-relief activities, and gamification of healthy behaviors like achieving step goals and eating healthy snacks

Real-world data confirms these results persist when patients maintain medication use and lifestyle modifications

The approval marks the seventh for the anti-PD-1 superstar in gastrointestinal cancer and its 38th overall in the U.S